Fred Hutch’s collaborative culture allows our researchers to generate discoveries as quickly as possible and translate them into new treatments, diagnostic tools and preventive strategies. Our integrated research centers, institutes, networks and other cross-divisional programs are crucial to maintaining that culture.
HICOR is a research institute at Fred Hutch whose mission is to improve cancer prevention, detection and treatment in ways that will reduce the economic and human burden of cancer — and ultimately lead to better outcomes for patients.
To achieve this, HICOR brings together researchers, patient partners, clinicians, payers and policymakers to share cancer-related data and generate clinically relevant performance metrics that can guide improvements in cancer care.
Fred Hutch has a growing cross-divisional Global Oncology program that investigates globally relevant cancers and seeks to understand the varied genetics and biology of common cancers around the world. Through our Global Oncology program, we aim to develop high-impact, low-cost diagnostic tools and therapies that can be used in low-resource settings worldwide.
The Fred Hutch Innovation Lab is spurring novel technology development and adoption. Scientists are leading the in-house development and early adoption of powerful new research technologies that hold the potential to drive lifesaving discoveries in cancer immunology and other areas of science.
Our world-class scientists have revolutionized prevention, detection and treatment of many cancers and other diseases.
Researchers in our five scientific divisions are generating pathbreaking discoveries and translating them into interventions that save lives.